- Home
- POCI vs BRNS Comparison
POCI vs BRNS Comparison
Compare POCI & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POCI
- BRNS
- Stock Information
- Founded
- POCI 1982
- BRNS 2016
- Country
- POCI United States
- BRNS United Kingdom
- Employees
- POCI N/A
- BRNS N/A
- Industry
- POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- POCI Health Care
- BRNS Health Care
- Exchange
- POCI Nasdaq
- BRNS Nasdaq
- Market Cap
- POCI 31.0M
- BRNS 28.2M
- IPO Year
- POCI N/A
- BRNS 2021
- Fundamental
- Price
- POCI $3.95
- BRNS $0.73
- Analyst Decision
- POCI
- BRNS Strong Buy
- Analyst Count
- POCI 0
- BRNS 2
- Target Price
- POCI N/A
- BRNS $3.00
- AVG Volume (30 Days)
- POCI 11.7K
- BRNS 24.3K
- Earning Date
- POCI 05-14-2025
- BRNS 05-12-2025
- Dividend Yield
- POCI N/A
- BRNS N/A
- EPS Growth
- POCI N/A
- BRNS N/A
- EPS
- POCI N/A
- BRNS N/A
- Revenue
- POCI $18,682,766.00
- BRNS $14,969,000.00
- Revenue This Year
- POCI N/A
- BRNS N/A
- Revenue Next Year
- POCI N/A
- BRNS N/A
- P/E Ratio
- POCI N/A
- BRNS N/A
- Revenue Growth
- POCI N/A
- BRNS 1766.46
- 52 Week Low
- POCI $3.47
- BRNS $0.64
- 52 Week High
- POCI $6.90
- BRNS $2.77
- Technical
- Relative Strength Index (RSI)
- POCI 40.65
- BRNS 37.21
- Support Level
- POCI $3.90
- BRNS $0.68
- Resistance Level
- POCI $4.28
- BRNS $0.75
- Average True Range (ATR)
- POCI 0.28
- BRNS 0.08
- MACD
- POCI -0.00
- BRNS -0.00
- Stochastic Oscillator
- POCI 19.57
- BRNS 25.00
About POCI Precision Optics Corporation Inc.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.